Enigma sign real-time PCR license with Applera

11-Feb-2008

Flexible pipetting system for high throughput - CyBio Well vario

Efficient method development with YMC-Triart chromatography columns

BACTRON/BACTROX Anaerobic Chambers – perfect control of anaerobic and hypoxic work processes

Enigma Diagnostics announced that it has signed license agreements with Applera Corporation. The licenses, signed 6 February 2008, include a Real-Time Instrument Patent License Agreement and an Application Kit License Agreement. These agreements provide Enigma with access under patents owned or controlled by Applera for real-time PCR thermal cyclers and real-time PCR methods and compositions in specific fields.

The Real-Time Instrument Patent License Agreement covers Enigma's current and pipeline instrument platforms of fully automated, real-time thermal cyclers across the commercial market sectors of research and applied markets. This agreement also provides Enigma with an option for a license in clinical diagnostics.

The Application Kit License Agreement covers a portfolio of important patents covering reverse transcription-based methods, real-time PCR detection process and 5' Nuclease assays and compositions, for use in fields excluding human diagnostics

Financial terms were not disclosed.

https://www.bionity.com/en/news/77728/enigma-sign-real-time-pcr-license-with-applera.html